Open AccessCinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease
Author(s) -
Nikhil Y. Patil,
Iulia Rus,
Emma Downing,
Ashok Mandala,
Jacob E. Friedman,
Aditya Joshi
Publication year - 2022
Publication title -
journal of pharmacology and experimental therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.286
H-Index - 225
eISSN - 1521-0103
pISSN - 0022-3565
DOI - 10.1124/jpet.122.001301
Subject(s) - hepatoprotection , fatty liver , steatohepatitis , lipotoxicity , lipogenesis , medicine , steatosis , cd36 , nonalcoholic fatty liver disease , endocrinology , aryl hydrocarbon receptor , pharmacology , biology , chemistry , biochemistry , lipid metabolism , receptor , insulin resistance , insulin , glutathione , disease , gene , transcription factor , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom